This content is in French.
Adverse effects of intravesical injection of OnabotulinumtoxinA in patients with idiopathic overactive bladder or neurogenic detrusor: a systematic review and meta-analysis of randomised controlled trials
5 septembre 2024
Despite the efficacy of onabotulinumtoxinA, its safety profile remains a cause for concern.
This meta-analysis examined the major adverse events (AEs) associated with intravesical treatment with onabotulinumtoxinA in patients with neurogenic detrusor overactivity (NDO) and idiopathic overactive bladder (IAB).
Sign in to read the rest
Reserved for healthcare professionals, free registration.
